ML19099A211: Difference between revisions
Jump to navigation
Jump to search
StriderTol (talk | contribs) (Created page by program invented by StriderTol) |
StriderTol (talk | contribs) (Created page by program invented by StriderTol) |
||
Line 3: | Line 3: | ||
| issue date = 04/29/2019 | | issue date = 04/29/2019 | ||
| title = Federal Register Notice: Training and Experience Requirements for Radiopharmaceuticals Requiring a Written Directive, Draft Options for Public Comment and Public Meeting | | title = Federal Register Notice: Training and Experience Requirements for Radiopharmaceuticals Requiring a Written Directive, Draft Options for Public Comment and Public Meeting | ||
| author name = Kock A | | author name = Kock A, Lopas S | ||
| author affiliation = NRC/NMSS/DMSST/MSEB | | author affiliation = NRC/NMSS/DMSST/MSEB | ||
| addressee name = | | addressee name = |
Revision as of 08:15, 12 June 2019
ML19099A211 | |
Person / Time | |
---|---|
Issue date: | 04/29/2019 |
From: | Andrea Kock, Sarah Lopas NRC/NMSS/DMSST/MSEB |
To: | |
Sarah Lopas | |
References | |
NRC-2018-0230 | |
Download: ML19099A211 (12) | |
Text
- Federal Register
A. Status Quo
- B. Tailored Training and Experience Requirements
- 1. Limited AU for Alpha- or Beta-Emitting Radiopharmaceuticals
- 2. Limited AU for Unit-Dose, Patient-Ready Radiopharmaceuticals *3. Limited AU for Any One Parenteral Radiopharmaceutical
- 4. Emerging Radiopharmaceuticals C. Performance-Based 1. Competency-Based Evaluation *
- 2. Credentialing of Authorized Users
- D. Team-Based *
- 1. Radiopharmaceutical Team
- 2. Team AUs with Authorized Administrators 3. Partner Limited-Trained AUs with Authorized Nuclear Pharmacists
/RA/